Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. to extend its PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications, the companies announced Tuesday.
The expanded relationship is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes.
The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
Datavault AI’s platform serves multiple industries, including high-performance computing software licensing for sports and entertainment, events and venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity.
This expansion into commercial healthcare represents a significant step for Datavault AI as it leverages its Web 3.0 and high-performance computing capabilities to address data management challenges in the healthcare sector. The partnership aims to create new revenue streams by allowing patients to control and monetize their health data.
The decision to restructure the transaction from preferred to common shares indicates a strategic alignment between the two companies, potentially simplifying the ownership structure and aligning incentives for future growth.
For more details, the full press release is available at https://ibn.fm/vBAxH. Additional information about Datavault AI can be found at https://dvlt.ai.
This development highlights the growing intersection of blockchain technology and healthcare, with potential implications for data security, patient autonomy, and the monetization of health information. As the global health and wellness market expands, such partnerships could become more prevalent, driving innovation in how health data is managed and utilized.
